Maria Abreu, MD: Ustekinumab as a First Line Treatment for Ulcerative Colitis
With the recent FDA approval, ustekinumab could be the first choice to treat ulcerative colitis.
Видео Maria Abreu, MD: Ustekinumab as a First Line Treatment for Ulcerative Colitis канала HCPLive
Видео Maria Abreu, MD: Ustekinumab as a First Line Treatment for Ulcerative Colitis канала HCPLive
Показать
Комментарии отсутствуют
Информация о видео
Другие видео канала
Pediatric Status Epilepticus A Challenge For PhysiciansPreventing Opportunistic Infections in HIVThe Future of Hepatic Encephalopathy ManagementApproaching Therapy for IBS: Diet ModificationPipeline Agents for the Treatment of Beta-ThalassemiaImportance of Relapse Prevention in SchizophreniaCommon Therapies in Lipodystrophy TreatmentCognitive Assessment Tools in Alzheimer DiseaseAndrea Dunaif, MD: PCOS Prevalence in Women with Type 2 DiabetesOptimal Treatment of Schizophrenia: Take-Home MessagesOverview of COPD MedicationsBenefits and Limitations of Nebulizers in COPDClostridium Difficile: The Role of BezlotoxumabSwitching HIV Therapy in Patients With Viral SuppressionUnderstanding Transfusion for Beta-ThalassemiaDuchenne Muscular Dystrophy and its Treatment OptionsPreparing Patients for Insulin in Type 2 DiabetesNutrition and Overall Health Status in Elderly PatientsClostridium Difficile: Avoiding High-Risk AntibioticsPreston Klassen, MD: Potential of Etrasimod Outside of IBS/IBDBruce Neal on the CANVAS trial for diabetes